Superior processability of Antheraea mylitta silk with cryo-milling: Performance in bone tissue regeneration

• Published in: International journal of biological macromolecules 2022-07, Vol.213, p.155-165
• Main Authors: Parekh, Nimisha, C.K., Bijosh, Kane, Kartiki, Panicker, Alaka, Nisal, Anuya, Wangikar, Pralhad, Agawane, Sachin
• Format: Article
• Language: English
• Subjects: Bone tissue engineering; Calvarial defect; hMSCs; Non-mulberry silk fiber; Processing technique
• ISSN: 0141-8130; 1879-0003
• DOI: 10.1016/j.ijbiomac.2022.05.122

Non-mulberry silk polymers have a promising future in biomedical applications. However, the dissolution of non-mulberry silk fiber is a still challenge and this poor processability has limited the use of this material. Here, we report a unique protocol to process the Antheraea mylitta (AM) silk fiber. We have shown that the cryo-milling of silk fiber reduces the beta sheet content by more than 10% and results in an SF powder that completely dissolves in routine solvents like trifluoroacetic acid (TFA) within few hours to form highly concentrated solutions (~20 wt%). Further, these solutions can be processed using conventional processing techniques such as electrospinning to form 3D scaffolds. Bombyx mori (BM) silk was used as a control sample in the study. In-vitro studies were also performed to monitor cell adhesion and proliferation and hMSCs differentiation into osteogenic lineage. Finally, the osteogenic potential of the scaffolds was also evaluated by a 4-week implantation study in rat calvarial model. The in-vitro and in-vivo results show that the processing techniques do not affect the biocompatibility of the material and the AM scaffolds support bone regeneration. Our results, thus, show that cryo-milling facilitates enhanced processability of non-mulberry silk and therefore expands its potential in biomedical applications.